Patients | | 529 | 25 | 504 |
Age years | 529 | 67 (52–77) | 70 (60–81) | 67 (51–77) |
Male | 529 | 247 (47) | 12 (48) | 235 (47) |
Cancer | 529 | 77 (15) | 7 (28) | 70 (14) |
Altered mental state | 529 | 7 (1) | 1 (4) | 6 (1) |
Syncope | 529 | 24 (5) | 2 (8) | 22 (4) |
Heart rate beats·min−1 | 526 | 88 (75–100) | 90 (80–103) | 88 (74–100) |
Systolic blood pressure mmHg | 529 | 134 (120–150) | 130 (124–140) | 135 (120–150) |
Cardiogenic shock on admission | 529 | 0 (0) | 0 (0) | 0 (0) |
PESI class | 529 | | | |
I (≤65 points) | | 131 (25) | 1 (4) | 130 (26) |
II (66–85 points) | | 198 (37) | 6 (24) | 192 (83) |
III (86–105 points) | | 109 (21) | 10 (40) | 99 (20) |
IV (106–125 points) | | 70 (13) | 5 (20) | 65 (13) |
V (>125 points) | | 21 (4) | 3 (12) | 18 (4) |
Echocardiography and cardiac biomarkers | | | | |
BNP ng·L−1 | 521 | 71.0 (27.0–210.0) | 275.0 (69.0–431.0) | 67.0 (27.0–190.0) |
Cardiac troponin I mg·L−1 | 517 | 0.01 (0.00–0.06) | 0.11 (0.01–0.34) | 0.01 (0.00–0.05) |
Right ventricle/left ventricle EDD ratio | 484 | 0.65 (0.53–0.79) | 0.76 (0.63–1.11) | 0.65 (0.53–0.79) |